Insights

Innovative Biotech Focus Vical specializes in developing DNA-based biopharmaceuticals for infectious diseases, presenting opportunities to collaborate with biotech firms seeking advanced therapeutic technologies and partnerships in genetic medicine.

Recent Strategic Mergers Following its merger with Brickell Biotech, Vical demonstrates a growth trajectory through strategic acquisitions, indicating potential for collaborations or sales involving novel therapeutic pipelines and combined research efforts.

Commercialization Licenses Vical's license agreement with Astellas Pharma for the antifungal candidate VL-2397 suggests openness to licensing deals, creating potential sales channels for complementary pharmaceutical products targeting similar markets.

Growing Market Presence With revenues between 25 and 50 million dollars and recent capital funding, Vical is positioned for expansion into new markets, providing opportunities for sales of research tools, development services, or partnering with emerging biotech initiatives.

Technological Engagement Utilizing industry-standard tech stacks like New Relic and Google Analytics, Vical is actively engaged in digital presence and data-driven development, opening avenues for sales of IT solutions, analytics services, or software tools to accelerate biotech R&D efforts.

Vical Incorporated Tech Stack

Vical Incorporated uses 6 technology products and services including jQuery, jQuery UI, New Relic, and more. Explore Vical Incorporated's tech stack below.

  • jQuery
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • New Relic
    Real User Monitoring
  • Google Analytics
    Web Analytics
  • Microsoft ASP.NET
    Web Frameworks
  • ShareThis
    Widgets

Media & News

Vical Incorporated's Email Address Formats

Vical Incorporated uses at least 1 format(s):
Vical Incorporated Email FormatsExamplePercentage
FLast@vical.comJDoe@vical.com
34%
First.Last@vical.comJohn.Doe@vical.com
22%
Last@vical.comDoe@vical.com
10%
FLast@vical.comJDoe@vical.com
34%

Frequently Asked Questions

What is Vical Incorporated's phone number?

Minus sign iconPlus sign icon
You can contact Vical Incorporated's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vical Incorporated's stock symbol?

Minus sign iconPlus sign icon
Vical Incorporated is a publicly traded company; the company's stock symbol is FRTX.

What is Vical Incorporated's official website and social media links?

Minus sign iconPlus sign icon
Vical Incorporated's official website is vical.com and has social profiles on LinkedInCrunchbase.

What is Vical Incorporated's SIC code NAICS code?

Minus sign iconPlus sign icon
Vical Incorporated's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vical Incorporated have currently?

Minus sign iconPlus sign icon
As of December 2025, Vical Incorporated has approximately 280 employees across 5 continents, including North AmericaSouth AmericaAfrica. Key team members include Cio-Consulting Services Director: A. P. S.Owner: C. Z.Design Department Head: D. C.. Explore Vical Incorporated's employee directory with LeadIQ.

What industry does Vical Incorporated belong to?

Minus sign iconPlus sign icon
Vical Incorporated operates in the Biotechnology Research industry.

What technology does Vical Incorporated use?

Minus sign iconPlus sign icon
Vical Incorporated's tech stack includes jQueryjQuery UINew RelicGoogle AnalyticsMicrosoft ASP.NETShareThis.

What is Vical Incorporated's email format?

Minus sign iconPlus sign icon
Vical Incorporated's email format typically follows the pattern of FLast@vical.com. Find more Vical Incorporated email formats with LeadIQ.

How much funding has Vical Incorporated raised to date?

Minus sign iconPlus sign icon
As of December 2025, Vical Incorporated has raised $25M in funding. The last funding round occurred on Nov 08, 2017 for $25M.

When was Vical Incorporated founded?

Minus sign iconPlus sign icon
Vical Incorporated was founded in 1987.

Vical Incorporated

Biotechnology ResearchCalifornia, United States201-500 Employees

Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing therapies, and is partnering with key industry leaders.

Additional information on Vical is available at www.vical.com.

Section iconCompany Overview

Phone number
Website
vical.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FRTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1987
Employees
201-500

Section iconFunding & Financials

  • $25M

    Vical Incorporated has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Nov 08, 2017 in the amount of $25M.

  • $25M$50M

    Vical Incorporated's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M

    Vical Incorporated has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Nov 08, 2017 in the amount of $25M.

  • $25M$50M

    Vical Incorporated's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.